Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-09, Stock:PFE, The news for the past five days is as follows:
2018-10-02: NEWS1: Is Pfizer (PFE) Stock Outpacing Its Medical Peers This Year?.NEWS2: Is Pfizer (PFE) Stock Outpacing Its Medical Peers This Year?.NEWS3: Pfizer's CEO Ian Read to Step Down Next Year, COO to Succeed.NEWS4: Pfizer's CEO Ian Read to Step Down Next Year, COO to Succeed.NEWS5: QIAGEN's FDA Nod for Expanded EGFR Test Use Widens Suite.NEWS6: QIAGEN's FDA Nod for Expanded EGFR Test Use Widens Suite.NEWS7: Why Pfizer (PFE) is a Great Dividend Stock Right Now.NEWS8: Why Pfizer (PFE) is a Great Dividend Stock Right Now.NEWS9: Examining the Performances of Eli Lilly’s Oncology Products.NEWS10: Pfizer&apos;s CEO Ian Read to Step Down Next Year, COO to Succeed.NEWS11: Is Pfizer (PFE) Stock Outpacing Its Medical Peers This Year?.NEWS12: Why Pfizer (PFE) is a Great Dividend Stock Right Now.NEWS13: QIAGEN&apos;s FDA Nod for Expanded EGFR Test Use Widens Suite.NEWS14: A Look at GlaxoSmithKline’s Consumer Healthcare Business.NEWS15: Does Mylan’s Low Valuation Provide a ‘Buy’ Opportunity?.NEWS16: A Closer Look at Eli Lilly’s Human Pharmaceutical Business.NEWS17: [$$] Since 2000 GE has paid $6bn in adviser fees. Was it worth it?.NEWS18: [$$] Pfizer: pill will.NEWS19: [$$] EpiPen dearth shows company and regulator failure.NEWS20: [$$] Pfizer Counts on Pipeline to Bring Growth.NEWS21: [$$] Pfizer CEO Read to Step Aside at Year’s End.NEWS22: PRESS DIGEST- British Business - Oct 2.
2018-10-03: NEWS1: Merck CEO sees a disintermediation in pharma like the cable industry.NEWS2: How Did Pharmaceutical ETFs Perform in Q3 2018?.NEWS3: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS4: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS5: Notable ETF Inflow Detected - SPYG, ABT, INTC, PFE.NEWS6: Notable ETF Inflow Detected - SPYG, ABT, INTC, PFE.NEWS7: A Look at Elanco, Eli Lilly’s Animal Health Business.NEWS8: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS9: Health Care Sector Update for 10/03/2018: JNJ, PFE, AMGN, MRK, ABT, ELGX, NVCN, KALA.NEWS10: Health Care Sector Update for 10/03/2018: JNJ, PFE, AMGN, MRK, ABT, ELGX, NVCN, KALA.NEWS11: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 04, 2018.NEWS12: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 04, 2018.NEWS13: How Have Eli Lilly’s Endocrine Products Been Performing?.NEWS14: [$$] Lex letter from New York: chiefs checked.NEWS15: Wide Moat Surrounds Pfizer's Solid Foundation.NEWS16: The 5 Best Dow Jones Stocks to Buy Now.NEWS17: The 5 Best Dow Jones Stocks to Buy Now.NEWS18: With Hemlibra, Roche seeks to break into tight hemophilia circle.
2018-10-04: NEWS1: Top Performing ETFs of the Third Quarter.NEWS2: Top Performing ETFs of the Third Quarter.NEWS3: What AbbVie’s Valuation Trend Indicates.NEWS4: Seattle Genetics: Impact of the Cascadian Acquisition.NEWS5: Antares Pharma Is Expected to Report Positive EPS in 2019.NEWS6: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS7: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS8: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS9: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS10: Amgen’s Stock Performance and Estimates after Q3 2018.NEWS11: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS12: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS13: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS14: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS15: How Did Pfizer Stock Fare in Q3 2018?.NEWS16: Eli Lilly’s Stock Performance and Estimates for Q3 2018.NEWS17: Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US.
2018-10-05: NEWS1: Dow Tumbles 180 Points to End Lower for the Week.NEWS2: Dow Tumbles 180 Points to End Lower for the Week.NEWS3: Johnson & Johnson Stock in the Week Ended October 5.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,788.45 down -91.06 points.NEWS5: Market Close Report: NASDAQ Composite index closes at 7,788.45 down -91.06 points.NEWS6: Gilead Sciences: What to Expect from the Top Line.NEWS7: How’s Gilead Sciences Positioned in October?.NEWS8: Rising Yields Pose Risk to Large-Cap Pharma&apos;s Red-Hot Rally.NEWS9: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps '18 View.NEWS10: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps '18 View.NEWS11: Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data.NEWS12: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS13: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS14: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps &apos;18 View.NEWS15: What Seattle Genetics’ Valuation Trend Indicates.NEWS16: Sangamo Therapeutics: Analysts Expect 88% Upside Potential.
2018-10-08: NEWS1: Dow Rallies Back, S&P 500 Retakes Key Support As Tech Stocks Fall.NEWS2: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS3: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS4: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS5: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS6: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS7: The Uphill Fight Against Fake Prescription Drugs.NEWS8: Health Care Digest: Upsized record IPO, e-cigarette questions, a CEO Dance and more.NEWS9: PFE Crosses Above Average Analyst Target.NEWS10: PFE Crosses Above Average Analyst Target.NEWS11: Johnson & Johnson’s Valuation Trend in October.NEWS12: Gilead Sciences Stock: Analysts’ Recommendations.NEWS13: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS14: How Much Upside Potential Do Analysts See in JNJ Stock?.NEWS15: Pfizer May Rise 8% to Highest Price Since 2000.NEWS16: AP FACT CHECK: Trump fudges history on black vote, drug cost.NEWS17: AP FACT CHECK: Trump fudges history on black vote, drug cost.

Answer: Rise